81 – 90 of 202
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Mechanisms of Dopamine D1 Receptor-Mediated ERK1/2 Activation in the Parkinsonian Striatum and Their Modulation by Metabotropic Glutamate Receptor Type 5.
(2014) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 34(13). p.4728-4740
- Contribution to journal › Article
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
- Contribution to journal › Article
-
Mark
Nigral 6-hydroxydopamine lesion impairs performance in a lateralised choice reaction time task-Impact of training and task parameters
- Contribution to journal › Article
-
Mark
Sigma-1 receptor: a potential new target for Parkinson's disease?
- Contribution to journal › Debate/Note/Editorial
-
Mark
Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.
- Contribution to journal › Article
-
Mark
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
(2014) In Proceedings of the National Academy of Sciences of the United States of America 111(12). p.4578-4583
- Contribution to journal › Article
-
Mark
Preclinical models of levodopa-induced dyskinesia
(2014) p.335-353
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
(2014) p.373-386
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals
- Contribution to journal › Article
